Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibiotics
antibiotics
Scientists Tracked Evolution Of Antibiotic Resistance In Real Time
Forbes
Wed, 05/29/19 - 10:45 pm
Evolution
antibiotics
antibiotic resistance
Immune To Drugs: Antimicrobial Resistance Could Kill 10 Million A Year
Forbes
Wed, 05/22/19 - 10:05 am
antibiotics
antibiotic resistance
Biotech hits the brakes on their PhIII pivotal for a lead antibiotic as investigators track a high rate of kidney injuries
Endpoints
Mon, 05/13/19 - 10:12 am
Polyphor
clinical trials
antibiotics
murepavadin
nosocomial pneumonia
Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge
Stat
Thu, 05/2/19 - 11:13 am
antibiotics
antibiotic resistance
R&D
drug development
Nabriva's Antibiotic Contempo Turned Down by FDA Over Manufacturing Issues
BioSpace
Wed, 05/1/19 - 10:56 am
Nabriva Therapeutics
Contempo
antibiotics
FDA
drug manufacturing
A decade of incentives to promote antibiotic development and still no viable route to commercial success
BioWorld
Thu, 04/25/19 - 11:19 pm
Achaogen
Zemdri
R&D
drug development
antibiotics
Forge Therapeutics, Basilea Sign Deal to Pursue New Antibiotics
Xconomy
Wed, 04/24/19 - 04:05 pm
antibiotics
drug development
Forge Therapeutics
Basilea
Lilly to sell legacy antibiotics, Ceclor and Vancocin, to China-based partner in $375M deal
Endpoints
Tue, 04/23/19 - 09:49 am
Eli Lilly
China
antibiotics
Ceclor
Vancocin
Eddingpharm
Achaogen’s bankruptcy and going-out-of-business sale offer a grim cautionary tale for the future of antibiotic development
Endpoints
Tue, 04/16/19 - 10:07 am
Achaogen
bankruptcy
antibiotics
drug development
Small biotech the ‘true engine’ of antibiotic innovation, as pharma ‘spews nonsense’ on its R&D: Jim O'Neill
Fierce Biotech
Sat, 03/30/19 - 01:07 pm
R&D
antibiotics
antibiotic resistance
Throwing in the towel, troubled antibiotic maker Aradigm files for Chapter 11
Endpoints
Tue, 02/19/19 - 10:05 am
Aradigm
antibiotics
bankruptcy
Apulmiq
The antibiotics R&D effort is broken. Here's one market solution that might fix it
Endpoints
Fri, 01/25/19 - 11:51 am
R&D
antibiotics
Novartis shares data on discontinued antibiotic research
BioCentury
Thu, 01/3/19 - 11:42 pm
Novartis
R&D
antibiotics
Genentech develop antibiotic with potential to lead to new class of antibiotics
Pharmaforum
Fri, 12/14/18 - 11:34 am
Genentech
G07750
antibiotics
drug development
antibiotic resistance
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Wed, 12/12/18 - 09:54 am
Eisai
Takeda
GARDP
antibiotics
R&D
Experimental treatment appears effective against gonorrhea in small study
Stat
Wed, 11/7/18 - 07:05 pm
gonorrhea
antibiotics
zoliflodacin
Entasis
Paratek caps 20-year R&D journey with FDA OK for its broad spectrum antibiotic — time to talk launch
Endpoints
Wed, 10/3/18 - 09:49 am
antibiotics
FDA
R&D
Paratek
Nuzyra
MicuRx Recieves Fast Track and QIDP Designations for MRSA Antiobiotics
CP WIre
Fri, 09/21/18 - 09:37 am
MicuRx Pharmaceuticals
MRX-1
contezolid
contezolid acefosamil
antibiotics
MRSA
MicuRx Recieves Fast Track and QIDP Designations for MRSA Antiobiotics
Fri, 09/21/18 - 09:05 am
MicuRx Pharmaceuticals
MRX-1
contezolid
contezolid acefosamil
antibiotics
MRSA
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases
CP Wire
Tue, 09/4/18 - 10:09 am
antibiotics
Boehringer Ingelheim
drug development
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »